Keith H Nuechterlein

Title(s)Professor-in-Residence, Psychiatry and Biobehavioral Sciences
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
    NIMH R01 MH130848May 1, 2023 - Mar 31, 2028
    Role: Principal Investigator
    Description: This confirmatory efficacy randomized controlled trial focuses on whether the combination of cognitive training and regular aerobic exercise provided through telehealth can improve cognition and work/school functioning after a first schizophrenia episode.
    Determining the Role of Social Reward Learning in Social Anhedonia in First-Episode Psychosis Using Motivational Interviewing as a Probe in a Perturbation-Based Neuroimaging Approach
    NIMH R01 MH129351Jan 1, 2023 - Oct 31, 2027
    Role: Multiple Principal Investigator
    Description: To examine the role of social reward learning in social anhedonia in first-episode psychosis, using brief motivational interviewing to examine changes in social learning performance and associated fMRI activation.
    Clinical Research Training in Schizophrenia and Other Psychoses
    NIH T32MH122395Jul 1, 2021 - Jun 30, 2026
    Role: Principal Investigator
    Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode
    NIH R01MH110544Sep 2, 2016 - Jun 30, 2021
    Role: Principal Investigator
    Enhancing Cognitive Training through Exercise after a First Schizophrenia Episode
    NIH R34MH102529Dec 1, 2013 - Nov 30, 2016
    Role: Principal Investigator
    Cognitive and Affective Dysfunctions in the Psychoses
    NIH T32MH096682Jul 1, 2013 - Jun 30, 2019
    Role: Principal Investigator
    Center for Neurocognition and Emotion in Schizophrenia
    NIH P50MH066286Jul 1, 2002 - Jun 30, 2016
    Role: Principal Investigator
    INTERVENTION RESEARCH TRAINING FOR THE PSYCHOSES
    NIH T32MH020059Jul 1, 2000 - Jun 30, 2005
    Role: Principal Investigator
    Transmission of Vulnerability Factors for Schizophrenia
    NIH R01MH049716Sep 1, 1994 - Mar 31, 2010
    Role: Principal Investigator
    Developmental Processes in Schizophrenic Disorders
    NIH R01MH037705Sep 15, 1983 - Nov 30, 2011
    Role: Principal Investigator
    Psychological Research on Schizophrenic Conditions
    NIH T32MH014584Jul 1, 1976 - Jun 30, 2011
    Role: Mentor and starting 1997 Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Fetal Gene Regulatory Gene Deletions are Associated with Poor Cognition and Altered Cortical Morphology in Schizophrenia and Community-Based Samples. medRxiv. 2024 Aug 06. Forsyth JK, Zhu J, Chavannes AS, Trevorrow ZH, Hyat M, Sievertsen SA, Ferreira-Ianone S, Conomos MP, Nuechterlein KH, Asarnow RF, Green MF, Karlsgodt KH, Perkins DO, Cannon TD, Addington JM, Cadenhead KS, Cornblatt BA, Keshavan MS, Mathalon DH, Stone WS, Tsuang MT, Walker EF, Woods SW, Narr KL, McEwen SC, Schleifer CH, Yee CM, Diehl CK, Guha A, Miller GA, Alexander-Bloch AF, Seidlitz J, Bethlehem RAI, Ophoff RA, Bearden CE. PMID: 39211869; PMCID: PMC11361264.
      View in: PubMed   Mentions:
    2. Measuring Cognitive Impairments Associated With Schizophrenia in Clinical Practice: Overview of Current Challenges and Future Opportunities. Schizophr Bull. 2024 Aug 01. Nuechterlein KH, Nasrallah H, Velligan D. PMID: 39088730.
      View in: PubMed   Mentions:    Fields:    
    3. Defeatist performance beliefs in individuals with recent-onset schizophrenia: Relationships with cognition and negative symptoms. Schizophr Res. 2024 Aug; 270:212-219. Filip TF, Hellemann GS, Ventura J, Subotnik KL, Green MF, Nuechterlein KH, McCleery A. PMID: 38924939; PMCID: PMC11323074.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Task-based default mode network connectivity predicts cognitive impairment and negative symptoms in first-episode schizophrenia. Psychophysiology. 2024 Oct; 61(10):e14627. Guha A, Popov T, Bartholomew ME, Reed AC, Diehl CK, Subotnik KL, Ventura J, Nuechterlein KH, Miller GA, Yee CM. PMID: 38924105; PMCID: PMC11473237.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Intrinsic motivation predicts cognitive and functional gains during coordinated specialty care for first-episode schizophrenia. Schizophr Res. 2024 Apr; 266:249-255. Le TP, Ventura J, Subotnik KL, Nuechterlein KH. PMID: 38442522.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Exercise behaviours and motivation after a first psychotic episode: A digital intervention. Early Interv Psychiatry. 2024 Oct; 18(10):805-813. Ruiz-Yu B, Le TP, Ventura J, Arevian A, Hellemann GS, Nuechterlein KH. PMID: 38356325; PMCID: PMC11322420.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Clarifying directional dependence among measures of early auditory processing and cognition in schizophrenia: leveraging Gaussian graphical models and Bayesian networks. Psychol Med. 2024 Jul; 54(9):1930-1939. Abplanalp SJ, Braff DL, Light GA, Joshi YB, Nuechterlein KH, Green MF, Consortium on the Genetics of Schizophrenia. PMID: 38287656; PMCID: PMC11413352.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. The relationship between sex and functional outcome in first-episode schizophrenia: the role of premorbid adjustment and insight. Psychol Med. 2023 Oct; 53(14):6878-6887. Ventura J, Subotnik KL, Han S, Hellemann GS, Green MF, Nuechterlein KH. PMID: 38314778; PMCID: PMC10600815.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden. Am J Psychiatry. 2023 07 01; 180(7):519-523. Joshi YB, Molina JL, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, Radant AD, Silverman JM, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Swerdlow NR, Light GA. PMID: 37038743.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Prospective, randomized, multicenter clinical trial evaluating longitudinal changes in brain function and microstructure in first-episode schizophrenia patients treated with long-acting injectable paliperidone palmitate versus oral antipsychotics. Schizophr Res. 2023 05; 255:222-232. Wang C, Tishler TA, Oughourlian T, Nuechterlein KH, de la Fuente-Sandoval C, Ellingson BM. PMID: 37019033.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Exercise Predicts a Good Night's Sleep: Preliminary Findings from a UCLA Study of First-Episode Schizophrenia. Behav Sci (Basel). 2023 Jan 21; 13(2). Subotnik KL, McEwen SC, Ventura J, Turner LR, Sturdevant Y, Niess TL, Casaus LR, Distler MG, Zito MF, Hellemann GS, Nguyen CD, Nuechterlein KH. PMID: 36829317; PMCID: PMC9952381.
      View in: PubMed   Mentions:
    12. The MATRICS Consensus Cognitive Battery: An Update. Curr Top Behav Neurosci. 2023; 63:1-18. Nuechterlein KH, Green MF, Kern RS. PMID: 36306054.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    13. Treatment engagement in first-episode schizophrenia: Associations between intrinsic motivation and attendance during cognitive training and an aerobic exercise program. Schizophr Res. 2023 01; 251:59-65. Le TP, Ventura J, Ruiz-Yu B, McEwen SC, Subotnik KL, Nuechterlein KH. PMID: 36577235; PMCID: PMC10163954.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Developmental trajectories of premorbid functioning predict cognitive remediation treatment response in first-episode schizophrenia. Psychol Med. 2023 10; 53(13):6132-6141. Kuo SS, Ventura J, Forsyth JK, Subotnik KL, Turner LR, Nuechterlein KH. PMID: 36349373; PMCID: PMC10166766.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Understanding Connections and Boundaries Between Positive Symptoms, Negative Symptoms, and Role Functioning Among Individuals With Schizophrenia: A Network Psychometric Approach. JAMA Psychiatry. 2022 10 01; 79(10):1014-1022. Abplanalp SJ, Braff DL, Light GA, Nuechterlein KH, Green MF, Consortium on the Genetics of Schizophrenia-2. PMID: 35976655; PMCID: PMC9386606.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    16. Dispersion of cognitive performance test scores on the MATRICS Consensus Cognitive Battery: A different perspective. Schizophr Res Cogn. 2022 Dec; 30:100270. Williamson DJ, Nuechterlein KH, Tishler T, Ventura J, Ellingson BM, Turkoz I, Keefe RSE, Alphs L. PMID: 36111288; PMCID: PMC9468588.
      View in: PubMed   Mentions:
    17. Aerobic exercise enhances cognitive training effects in first-episode schizophrenia: randomized clinical trial demonstrates cognitive and functional gains. Psychol Med. 2023 07; 53(10):4751-4761. Nuechterlein KH, McEwen SC, Ventura J, Subotnik KL, Turner LR, Boucher M, Casaus LR, Distler MG, Hayata JN. PMID: 36047035; PMCID: PMC10388302.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    18. Evaluation of major treatment failure in patients with recent-onset schizophrenia or schizophreniform disorder: A post hoc analysis from the Disease Recovery Evaluation and Modification (DREaM) study. Schizophr Res. 2022 10; 248:58-63. Alphs L, Baker P, Brown B, Fu DJ, Turkoz I, Nuechterlein KH. PMID: 35939921.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Value-directed remembering in first-episode schizophrenia. Neuropsychology. 2022 Sep; 36(6):540-551. Patterson TK, Nuechterlein KH, Subotnik KL, Castel AD, Knowlton BJ. PMID: 35737534; PMCID: PMC9945935.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022 04; 604(7906):502-508. Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen CY, Dennison CA, Hall LS, Lam M, Watanabe K, Frei O, Ge T, Harwood JC, Koopmans F, Magnusson S, Richards AL, Sidorenko J, Wu Y, Zeng J, Grove J, Kim M, Li Z, Voloudakis G, Zhang W, Adams M, Agartz I, Atkinson EG, Agerbo E, Al Eissa M, Albus M, Alexander M, Alizadeh BZ, Alptekin K, Als TD, Amin F, Arolt V, Arrojo M, Athanasiu L, Azevedo MH, Bacanu SA, Bass NJ, Begemann M, Belliveau RA, Bene J, Benyamin B, Bergen SE, Blasi G, Bobes J, Bonassi S, Braun A, Bressan RA, Bromet EJ, Bruggeman R, Buckley PF, Buckner RL, Bybjerg-Grauholm J, Cahn W, Cairns MJ, Calkins ME, Carr VJ, Castle D, Catts SV, Chambert KD, Chan RCK, Chaumette B, Cheng W, Cheung EFC, Chong SA, Cohen D, Consoli A, Cordeiro Q, Costas J, Curtis C, Davidson M, Davis KL, de Haan L, Degenhardt F, DeLisi LE, Demontis D, Dickerson F, Dikeos D, Dinan T, Djurovic S, Duan J, Ducci G, Dudbridge F, Eriksson JG, Fañanás L, Faraone SV, Fiorentino A, Forstner A, Frank J, Freimer NB, Fromer M, Frustaci A, Gadelha A, Genovese G, Gershon ES, Giannitelli M, Giegling I, Giusti-Rodríguez P, Godard S, Goldstein JI, González Peñas J, González-Pinto A, Gopal S, Gratten J, Green MF, Greenwood TA, Guillin O, Gülöksüz S, Gur RE, Gur RC, Gutiérrez B, Hahn E, Hakonarson H, Haroutunian V, Hartmann AM, Harvey C, Hayward C, Henskens FA, Herms S, Hoffmann P, Howrigan DP, Ikeda M, Iyegbe C, Joa I, Julià A, Kähler AK, Kam-Thong T, Kamatani Y, Karachanak-Yankova S, Kebir O, Keller MC, Kelly BJ, Khrunin A, Kim SW, Klovins J, Kondratiev N, Konte B, Kraft J, Kubo M, Kucinskas V, Kucinskiene ZA, Kusumawardhani A, Kuzelova-Ptackova H, Landi S, Lazzeroni LC, Lee PH, Legge SE, Lehrer DS, Lencer R, Lerer B, Li M, Lieberman J, Light GA, Limborska S, Liu CM, Lönnqvist J, Loughland CM, Lubinski J, Luykx JJ, Lynham A, Macek M, Mackinnon A, Magnusson PKE, Maher BS, Maier W, Malaspina D, Mallet J, Marder SR, Marsal S, Martin AR, Martorell L, Mattheisen M, McCarley RW, McDonald C, McGrath JJ, Medeiros H, Meier S, Melegh B, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mitjans M, Molden E, Molina E, Molto MD, Mondelli V, Moreno C, Morley CP, Muntané G, Murphy KC, Myin-Germeys I, Nenadic I, Nestadt G, Nikitina-Zake L, Noto C, Nuechterlein KH, O'Brien NL, O'Neill FA, Oh SY, Olincy A, Ota VK, Pantelis C, Papadimitriou GN, Parellada M, Paunio T, Pellegrino R, Periyasamy S, Perkins DO, Pfuhlmann B, Pietiläinen O, Pimm J, Porteous D, Powell J, Quattrone D, Quested D, Radant AD, Rampino A, Rapaport MH, Rautanen A, Reichenberg A, Roe C, Roffman JL, Roth J, Rothermundt M, Rutten BPF, Saker-Delye S, Salomaa V, Sanjuan J, Santoro ML, Savitz A, Schall U, Scott RJ, Seidman LJ, Sharp SI, Shi J, Siever LJ, Sigurdsson E, Sim K, Skarabis N, Slominsky P, So HC, Sobell JL, Söderman E, Stain HJ, Steen NE, Steixner-Kumar AA, Stögmann E, Stone WS, Straub RE, Streit F, Strengman E, Stroup TS, Subramaniam M, Sugar CA, Suvisaari J, Svrakic DM, Swerdlow NR, Szatkiewicz JP, Ta TMT, Takahashi A, Terao C, Thibaut F, Toncheva D, Tooney PA, Torretta S, Tosato S, Tura GB, Turetsky BI, Üçok A, Vaaler A, van Amelsvoort T, van Winkel R, Veijola J, Waddington J, Walter H, Waterreus A, Webb BT, Weiser M, Williams NM, Witt SH, Wormley BK, Wu JQ, Xu Z, Yolken R, Zai CC, Zhou W, Zhu F, Zimprich F, Atbasoglu EC, Ayub M, Benner C, Bertolino A, Black DW, Bray NJ, Breen G, Buccola NG, Byerley WF, Chen WJ, Cloninger CR, Crespo-Facorro B, et al. PMID: 35396580; PMCID: PMC9392466.
      View in: PubMed   Mentions: 684     Fields:    Translation:Humans
    21. The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorder. Schizophr Res. 2022 05; 243:86-97. Alphs L, Brown B, Turkoz I, Baker P, Fu DJ, Nuechterlein KH. PMID: 35247794.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    22. Confident memory errors and disrupted reality testing in early psychosis. Schizophr Res. 2021 12; 238:170-177. Seabury RD, Bearden CE, Ventura J, Subotnik KL, Nuechterlein KH, Cannon TD. PMID: 34710715.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Linguistic and neurocognitive correlates of probabilistic classification learning in schizophrenia. Schizophr Res Cogn. 2021 Dec; 26:100209. Fernandez VG, Asarnow R, Hodges M, Nuechterlein KH. PMID: 34354933; PMCID: PMC8321954.
      View in: PubMed   Mentions: 1  
    24. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia. Am J Psychiatry. 2021 09 01; 178(9):838-847. Joshi YB, Thomas ML, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, MacDonald LR, Molina JL, Nungaray JA, Radant AD, Silverman JM, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Swerdlow NR, Light GA. PMID: 33985348; PMCID: PMC8440496.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    25. Cortical morphometric correlational networks associated with cognitive deficits in first episode schizophrenia. Schizophr Res. 2021 05; 231:179-188. Wang C, Oughourlian T, Tishler TA, Anwar F, Raymond C, Pham AD, Perschon A, Villablanca JP, Ventura J, Subotnik KL, Nuechterlein KH, Ellingson BM. PMID: 33872855.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. Awareness of illness is associated with better social and nonsocial cognition in recent-onset schizophrenia. Schizophr Res. 2021 05; 231:51-53. Zito MF, Subotnik KL, Ventura J, Kern RS, Green MF, Nuechterlein KH. PMID: 33770625; PMCID: PMC10758255.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Cognitive heterogeneity in first-episode psychosis and its relationship with premorbid developmental adjustment. Psychol Med. 2021 Mar 12; 1-10. Tan EJ, Rossell SL, Subotnik KL, Ventura J, Nuechterlein KH. PMID: 33706841.
      View in: PubMed   Mentions: 8     Fields:    
    28. The clinical characterization of the patient with primary psychosis aimed at personalization of management. World Psychiatry. 2021 Feb; 20(1):4-33. Maj M, van Os J, De Hert M, Gaebel W, Galderisi S, Green MF, Guloksuz S, Harvey PD, Jones PB, Malaspina D, McGorry P, Miettunen J, Murray RM, Nuechterlein KH, Peralta V, Thornicroft G, van Winkel R, Ventura J. PMID: 33432763; PMCID: PMC7801854.
      View in: PubMed   Mentions: 102  
    29. Heritability of acoustic startle magnitude and latency from the consortium on the genetics of schizophrenia. Schizophr Res. 2020 10; 224:33-39. Greenwood TA, Swerdlow NR, Sprock J, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL, Duncan E. PMID: 33189519; PMCID: PMC7728376.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Structural and Functional Connectivity of Visual Cortex in Schizophrenia and Bipolar Disorder: A Graph-Theoretic Analysis. Schizophr Bull Open. 2020 Jan; 1(1):sgaa056. Reavis EA, Lee J, Altshuler LL, Cohen MS, Engel SA, Glahn DC, Jimenez AM, Narr KL, Nuechterlein KH, Riedel P, Wynn JK, Green MF. PMID: 33313506; PMCID: PMC7712743.
      View in: PubMed   Mentions: 5  
    31. A randomized controlled trial of cognitive remediation and long-acting injectable risperidone after a first episode of schizophrenia: improving cognition and work/school functioning. Psychol Med. 2022 06; 52(8):1517-1526. Nuechterlein KH, Ventura J, Subotnik KL, Gretchen-Doorly D, Turner LR, Casaus LR, Luo J, Boucher ML, Hayata JN, Bell MD, Medalia A. PMID: 32981534.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    32. Early Visual Processing Is Associated With Social Cognitive Performance in Recent-Onset Schizophrenia. Front Psychiatry. 2020; 11:823. McCleery A, Wynn JK, Lee J, Reavis EA, Ventura J, Subotnik KL, Green MF, Nuechterlein KH. PMID: 33192628; PMCID: PMC7478198.
      View in: PubMed   Mentions: 7  
    33. Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients. Schizophr Res. 2020 08; 222:397-410. Chwa WJ, Tishler TA, Raymond C, Tran C, Anwar F, Villablanca JP, Ventura J, Subotnik KL, Nuechterlein KH, Ellingson BM. PMID: 32487466; PMCID: PMC7572538.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    34. The effects of age and sex on cognitive impairment in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS) study. PLoS One. 2020; 15(5):e0232855. Lee J, Green MF, Nuechterlein KH, Swerdlow NR, Greenwood TA, Hellemann GS, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Gur RC, Gur RE, Braff DL. PMID: 32401791; PMCID: PMC7219730.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    35. Personnel time required for supported employment and education services for individuals in a recent-onset psychosis treatment program. Early Interv Psychiatry. 2021 04; 15(2):402-405. Humensky JL, Turner LR, Dixon LB, Drake RE, Becker DR, Subotnik KL, Ventura J, Nuechterlein KH. PMID: 32351048; PMCID: PMC7606755.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    36. Relationship of poor insight to neurocognition, social cognition, and psychiatric symptoms in schizophrenia: A meta-analysis. Schizophr Res. 2020 06; 220:164-171. Subotnik KL, Ventura J, Hellemann GS, Zito MF, Agee ER, Nuechterlein KH. PMID: 32334936.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    37. Computer-aided learning for managing stress: A feasibility trial with clinical high risk adolescents and young adults. Early Interv Psychiatry. 2021 06; 15(3):471-479. Woodberry KA, Chokran C, Johnson KA, Nuechterlein KH, Miklowitz DJ, Faraone SV, Seidman LJ. PMID: 32237208; PMCID: PMC8175018.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    38. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery. Schizophr Res. 2020 04; 218:85-92. Bezdicek O, Michalec J, Kališová L, Kufa T, Dechterenko F, Chlebovcová M, Havlík F, Green MF, Nuechterlein KH. PMID: 32089475.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    39. Changes in inflammation are related to depression and amount of aerobic exercise in first episode schizophrenia. Early Interv Psychiatry. 2021 02; 15(1):213-216. Ventura J, McEwen S, Subotnik KL, Hellemann GS, Ghadiali M, Rahimdel A, Seo MJ, Irwin MR, Nuechterlein KH. PMID: 32056388; PMCID: PMC7423726.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    40. Associations between physiological responses to social-evaluative stress and daily functioning in first-episode schizophrenia. Schizophr Res. 2020 04; 218:233-239. Reed AC, Lee J, Green MF, Hamilton HK, Miller GA, Subotnik KL, Ventura J, Nuechterlein KH, Yee CM. PMID: 31948901; PMCID: PMC7299766.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    41. Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study. JAMA Psychiatry. 2019 12 01; 76(12):1274-1284. Greenwood TA, Lazzeroni LC, Maihofer AX, Swerdlow NR, Calkins ME, Freedman R, Green MF, Light GA, Nievergelt CM, Nuechterlein KH, Radant AD, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Gur RC, Gur RE, Braff DL. PMID: 31596458; PMCID: PMC6802253.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    42. Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations
. Dialogues Clin Neurosci. 2019 09; 21(3):239-248. McCleery A, Nuechterlein KH. PMID: 31749648; PMCID: PMC6829172.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    43. Evidence of shared familial factors influencing neurocognitive endophenotypes in adult- and childhood-onset schizophrenia. Psychol Med. 2020 07; 50(10):1672-1679. Bigdeli TB, Nuechterlein KH, Sugar CA, Subotnik KL, Kubarych T, Neale MC, Kendler KS, Asarnow RF. PMID: 31362798.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    44. Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning. Early Interv Psychiatry. 2020 02; 14(1):106-114. Ventura J, Welikson T, Ered A, Subotnik KL, Keefe RSE, Hellemann GS, Nuechterlein KH. PMID: 31183960; PMCID: PMC6901817.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    45. Affective prosody and facial emotion recognition in first-episode schizophrenia: Associations with functioning & symptoms. Schizophr Res Cogn. 2019 Dec; 18:100153. Bonfils KA, Ventura J, Subotnik KL, Nuechterlein KH. PMID: 31497511; PMCID: PMC6718049.
      View in: PubMed   Mentions: 12  
    46. Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial. Schizophr Res. 2019 06; 208:182-189. Mahncke HW, Kim SJ, Rose A, Stasio C, Buckley P, Caroff S, Duncan E, Yasmin S, Jarskog LF, Lamberti JS, Nuechterlein K, Strassnig M, Velligan D, Ventura J, Walker T, Stroup TS, Keefe RSE. PMID: 30930034; PMCID: PMC6544484.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    47. Enhancing return to work or school after a first episode of schizophrenia: the UCLA RCT of Individual Placement and Support and Workplace Fundamentals Module training. Psychol Med. 2020 01; 50(1):20-28. Nuechterlein KH, Subotnik KL, Ventura J, Turner LR, Gitlin MJ, Gretchen-Doorly D, Becker DR, Drake RE, Wallace CJ, Liberman RP. PMID: 30606273; PMCID: PMC6620168.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    48. fMRI evidence of aberrant neural adaptation for objects in schizophrenia and bipolar disorder. Hum Brain Mapp. 2019 04 01; 40(5):1608-1617. Lee J, Reavis EA, Engel SA, Altshuler LL, Cohen MS, Glahn DC, Nuechterlein KH, Wynn JK, Green MF. PMID: 30575206; PMCID: PMC6655550.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    49. Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study. Schizophr Res. 2019 04; 206:291-299. Breier A, Buchanan RW, D'Souza D, Nuechterlein K, Marder S, Dunn W, Preskorn S, Macaluso M, Wurfel B, Maguire G, Kakar R, Highum D, Hoffmeyer D, Coskinas E, Litman R, Vohs JL, Radnovich A, Francis MM, Metzler E, Visco A, Mehdiyoun N, Yang Z, Zhang Y, Yolken RH, Dickerson FB. PMID: 30478008.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    50. Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia. Schizophr Res. 2019 02; 204:104-110. Clayson PE, Kern RS, Nuechterlein KH, Knowlton BJ, Bearden CE, Cannon TD, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee K, Lee J, Subotnik KL, Sugar CA, Ventura J, Yee CM, Green MF. PMID: 30121183; PMCID: PMC6377348.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. A direct examination of the cognitive underpinnings of multitasking abilities: A first study examining schizophrenia. Psychiatry Res. 2018 10; 268:288-296. Laloyaux J, Van der Linden M, Nuechterlein KH, Thonon B, Larøi F. PMID: 30081201.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. Family burden predicts functional outcome in the early course of schizophrenia beyond psychiatric symptoms and baseline functioning. Schizophr Res. 2018 12; 202:328-332. DeTore NR, Ventura J, Subotnik KL, Nuechterlein KH. PMID: 30539770; PMCID: PMC6599718.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    53. Episodic Memory for Dynamic Social Interaction Across Phase of Illness in Schizophrenia. Schizophr Bull. 2018 04 06; 44(3):620-630. Lee J, Nuechterlein KH, Knowlton BJ, Bearden CE, Cannon TD, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee K, Kern RS, Subotnik KL, Sugar CA, Ventura J, Yee CM, Green MF. PMID: 29106694; PMCID: PMC5890490.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    54. Temporal lobe thickness and verbal memory in first-degree relatives of individuals with schizophrenia. Schizophr Res. 2018 09; 199:221-225. Fernandez VG, Asarnow R, Narr KL, Subotnik KL, Kuppinger H, Fogelson D, Nuechterlein KH. PMID: 29499968; PMCID: PMC6110998.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    55. Connectivity-enhanced diffusion analysis reveals white matter density disruptions in first episode and chronic schizophrenia. Neuroimage Clin. 2018; 18:608-616. Grazioplene RG, Bearden CE, Subotnik KL, Ventura J, Haut K, Nuechterlein KH, Cannon TD. PMID: 29845009; PMCID: PMC5964624.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    56. Clinical and Cognitive Significance of Auditory Sensory Processing Deficits in Schizophrenia. Am J Psychiatry. 2018 03 01; 175(3):275-283. Hamilton HK, Williams TJ, Ventura J, Jasperse LJ, Owens EM, Miller GA, Subotnik KL, Nuechterlein KH, Yee CM. PMID: 29202656; PMCID: PMC5832530.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    57. Cognitive remediation can improve negative symptoms and social functioning in first-episode schizophrenia: A randomized controlled trial. Schizophr Res. 2019 01; 203:24-31. Ventura J, Subotnik KL, Gretchen-Doorly D, Casaus L, Boucher M, Medalia A, Bell MD, Hellemann GS, Nuechterlein KH. PMID: 29128326; PMCID: PMC6589092.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    58. Assessing neural tuning for object perception in schizophrenia and bipolar disorder with multivariate pattern analysis of fMRI data. Neuroimage Clin. 2017; 16:491-497. Reavis EA, Lee J, Wynn JK, Engel SA, Cohen MS, Nuechterlein KH, Glahn DC, Altshuler LL, Green MF. PMID: 28932681; PMCID: PMC5596305.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    59. Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension. Schizophr Res. 2018 08; 198:6-15. Swerdlow NR, Light GA, Thomas ML, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 28549722; PMCID: PMC5700873.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    60. Aerobic Exercise Improves Cognitive Functioning in People With Schizophrenia: A Systematic Review and Meta-Analysis. Schizophr Bull. 2017 May 01; 43(3):546-556. Firth J, Stubbs B, Rosenbaum S, Vancampfort D, Malchow B, Schuch F, Elliott R, Nuechterlein KH, Yung AR. PMID: 27521348; PMCID: PMC5464163.
      View in: PubMed   Mentions: 174     Fields:    Translation:Humans
    61. Abnormal Trajectory of Intracortical Myelination in Schizophrenia Implicates White Matter in Disease Pathophysiology and the Therapeutic Mechanism of Action of Antipsychotics. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 05; 3(5):454-462. Tishler TA, Bartzokis G, Lu PH, Raven EP, Khanoyan M, Kirkpatrick CJ, Pyle MH, Villablanca JP, Altshuler LL, Mintz J, Ventura J, Casaus LR, Subotnik KL, Nuechterlein KH, Ellingson BM. PMID: 29735155.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    62. The Pioneering Contributions of Irving Gottesman: An Appreciation. Clin Psychol Sci. 2017; 5(2):424-426. Nuechterlein KH. PMID: 28948093; PMCID: PMC5609475.
      View in: PubMed   Mentions:
    63. The Brazilian standardization of the MATRICS consensus cognitive battery (MCCB): Psychometric study. Schizophr Res. 2017 07; 185:148-153. Fonseca AO, Berberian AA, de Meneses-Gaya C, Gadelha A, Vicente MO, Nuechterlein KH, Bressan RA, Lacerda ALT. PMID: 28110814.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    64. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study. Schizophr Res. 2017 07; 185:137-143. Blanchard JJ, Bradshaw KR, Garcia CP, Nasrallah HA, Harvey PD, Casey D, Csoboth CT, Hudson JI, Julian L, Lentz E, Nuechterlein KH, Perkins DO, Skale TG, Snowden LR, Tandon R, Tek C, Velligan D, Vinogradov S, O'Gorman C. PMID: 28087270.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    65. Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia. JAMA Psychiatry. 2017 Jan 01; 74(1):37-46. Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Shiluk AL, Siever LJ, Silverman JM, Sprock J, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL, Light GA. PMID: 27926742; PMCID: PMC5453308.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    66. Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing. Schizophr Res. 2016 10; 176(2-3):467-472. McCleery A, Lee J, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee KS, Kern RS, Knowlton BJ, Subotnik KL, Ventura J, Sugar CA, Nuechterlein KH, Green MF. PMID: 27443808; PMCID: PMC5026923.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    67. Enhancing Cognitive Training Through Aerobic Exercise After a First Schizophrenia Episode: Theoretical Conception and Pilot Study. Schizophr Bull. 2016 07; 42 Suppl 1:S44-52. Nuechterlein KH, Ventura J, McEwen SC, Gretchen-Doorly D, Vinogradov S, Subotnik KL. PMID: 27460618; PMCID: PMC4960434.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    68. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophr Res. 2016 07; 174(1-3):1-9. Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, Siever L, Silverman J, Stone WS, Sprock J, Sugar CA, Swerdlow NR, Tsuang M, Turetsky B, Radant A, Tsuang DW. PMID: 27132484; PMCID: PMC4912929.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    69. Abnormal Ventral and Dorsal Attention Network Activity during Single and Dual Target Detection in Schizophrenia. Front Psychol. 2016; 7:323. Jimenez AM, Lee J, Wynn JK, Cohen MS, Engel SA, Glahn DC, Nuechterlein KH, Reavis EA, Green MF. PMID: 27014135; PMCID: PMC4781842.
      View in: PubMed   Mentions: 18  
    70. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophr Res. 2016 Apr; 172(1-3):106-13. Stone WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, McCarley RW, Heinssen R, Green MF, Nuechterlein K, Seidman LJ. PMID: 26896388; PMCID: PMC5410891.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    71. Cognitive Assessment Interview (CAI): Validity as a co-primary measure of cognition across phases of schizophrenia. Schizophr Res. 2016 Apr; 172(1-3):137-42. Ventura J, Subotnik KL, Ered A, Hellemann GS, Nuechterlein KH. PMID: 26852403; PMCID: PMC6528675.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    72. Expressed emotion and the escalation of depressive symptoms in individuals with recent-onset schizophrenia. Early Interv Psychiatry. 2017 08; 11(4):351-353. Rosenfarb IF, Triana S, Nuechterlein KH, Ventura J, Breitborde NJK. PMID: 26801739.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    73. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophr Res. 2016 Jan; 170(1):30-40. Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 26597662; PMCID: PMC4707095.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    74. Prefrontal and Hippocampal Brain Volume Deficits: Role of Low Physical Activity on Brain Plasticity in First-Episode Schizophrenia Patients. J Int Neuropsychol Soc. 2015 Nov; 21(10):868-79. McEwen SC, Hardy A, Ellingson BM, Jarrahi B, Sandhu N, Subotnik KL, Ventura J, Nuechterlein KH. PMID: 26581798; PMCID: PMC4654705.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    75. Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History. Am J Psychiatry. 2016 Apr 01; 173(4):385-91. Greenwood TA, Light GA, Swerdlow NR, Calkins ME, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Freedman R, Braff DL. PMID: 26441157; PMCID: PMC4933520.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    76. Factors predicting work outcome in Japanese patients with schizophrenia: role of multiple functioning levels. Schizophr Res Cogn. 2015 Sep; 2(3):105-112. Sumiyoshi C, Harvey PD, Takaki M, Okahisa Y, Sato T, Sora I, Nuechterlein KH, Subotnik KL, Sumiyoshi T. PMID: 29379760; PMCID: PMC5779305.
      View in: PubMed   Mentions: 8  
    77. Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial. JAMA Psychiatry. 2015 Aug; 72(8):822-9. Subotnik KL, Casaus LR, Ventura J, Luo JS, Hellemann GS, Gretchen-Doorly D, Marder S, Nuechterlein KH. PMID: 26107752; PMCID: PMC5065351.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansPHPublic Health
    78. The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: a focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilization. Schizophr Res. 2015 Aug; 166(1-3):69-79. Nasrallah HA, Harvey PD, Casey D, Csoboth CT, Hudson JI, Julian L, Lentz E, Nuechterlein KH, Perkins DO, Kotowsky N, Skale TG, Snowden LR, Tandon R, Tek C, Velligan D, Vinogradov S, O'Gorman C. PMID: 26027848.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    79. The RAISE Connection Program for Early Psychosis: Secondary Outcomes and Mediators and Moderators of Improvement. J Nerv Ment Dis. 2015 May; 203(5):365-71. Marino L, Nossel I, Choi JC, Nuechterlein K, Wang Y, Essock S, Bennett M, McNamara K, Mendon S, Dixon L. PMID: 25900546; PMCID: PMC4414797.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    80. Neurocognitive performance in family-based and case-control studies of schizophrenia. Schizophr Res. 2015 Apr; 163(1-3):17-23. Gur RC, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Gur RE. PMID: 25432636; PMCID: PMC4441547.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    81. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res. 2015 Apr; 163(1-3):38-46. Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 25749017; PMCID: PMC4382444.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    82. Contributions of Feature Binding During Encoding and Functional Connectivity of the Medial Temporal Lobe Structures to Episodic Memory Deficits Across the Prodromal and First-Episode Phases of Schizophrenia. Clin Psychol Sci. 2015 Mar; 3(2):159-174. Haut KM, van Erp TG, Knowlton B, Bearden CE, Subotnik K, Ventura J, Nuechterlein KH, Cannon TD. PMID: 25750836; PMCID: PMC4349206.
      View in: PubMed   Mentions: 11  
    83. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophr Res. 2015 Apr; 163(1-3):73-9. Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar C, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Green MF. PMID: 25682549; PMCID: PMC5944296.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    84. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies. Schizophr Res. 2015 Apr; 163(1-3):47-52. Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Sugar CA, Tsuang MT, Turetsky BI, Tsuang DW. PMID: 25553977; PMCID: PMC4382408.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    85. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res. 2015 Apr; 163(1-3):32-7. Stone WS, Mesholam-Gately RI, Braff DL, Calkins ME, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Siever LJ, Silverman JM, Sprock J, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Seidman LJ. PMID: 25497440; PMCID: PMC5954831.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    86. Hippocampal dysfunction during declarative memory encoding in schizophrenia and effects of genetic liability. Schizophr Res. 2015 Feb; 161(2-3):357-66. Pirnia T, Woods RP, Hamilton LS, Lyden H, Joshi SH, Asarnow RF, Nuechterlein KH, Narr KL. PMID: 25497222; PMCID: PMC4308444.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    87. Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later. Schizophr Res. 2015 Feb; 161(2-3):407-13. Ventura J, Subotnik KL, Gitlin MJ, Gretchen-Doorly D, Ered A, Villa KF, Hellemann GS, Nuechterlein KH. PMID: 25499044; PMCID: PMC4308531.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    88. The MATRICS consensus cognitive battery: what we know 6 years later. Am J Psychiatry. 2014 Nov 01; 171(11):1151-4. Green MF, Harris JG, Nuechterlein KH. PMID: 25756630.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    89. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophr Res. 2015 Apr; 163(1-3):63-72. Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Pela M, Radant AD, Seidman LJ, Sharp RF, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Braff DL, Turetsky BI. PMID: 25449710; PMCID: PMC4382452.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    90. Social cognition and functional outcome in schizophrenia: The moderating role of cardiac vagal tone. J Abnorm Psychol. 2014 Nov; 123(4):764-770. Hamilton HK, Sun JC, Green MF, Kee KS, Lee J, Sergi M, Sholty GL, Mathis KI, Jetton C, Williams TJ, Kern R, Horan W, Fiske A, Subotnik KL, Ventura J, Hellemann G, Nuechterlein KH, Yee CM. PMID: 25314266; PMCID: PMC4227946.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    91. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2. Schizophr Res. 2015 Apr; 163(1-3):53-62. Turetsky BI, Dress EM, Braff DL, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Light G. PMID: 25306203; PMCID: PMC4382423.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    92. Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications. Schizophr Res. 2015 Apr; 163(1-3):24-31. Lee J, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 25248939; PMCID: PMC4368500.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    93. Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. Schizophr Res. 2014 Oct; 159(1):182-7. Gray BE, McMahon RP, Green MF, Seidman LJ, Mesholam-Gately RI, Kern RS, Nuechterlein KH, Keefe RS, Gold JM. PMID: 25156338; PMCID: PMC4469996.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    94. The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia. Schizophr Res. 2014 Oct; 159(1):95-100. Subotnik KL, Ventura J, Gretchen-Doorly D, Hellemann GS, Agee ER, Casaus LR, Luo JS, Villa KF, Nuechterlein KH. PMID: 25108771; PMCID: PMC4177349.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    95. Developing a Cognitive Training Strategy for First-Episode Schizophrenia: Integrating Bottom-Up and Top-Down Approaches. Am J Psychiatr Rehabil. 2014 Jul; 17(3):225-253. Nuechterlein KH, Ventura J, Subotnik KL, Hayata JN, Medalia A, Bell MD. PMID: 25489275; PMCID: PMC4256669.
      View in: PubMed   Mentions: 15  
    96. Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study. Schizophr Bull. 2014 Nov; 40(6):1404-11. Light G, Greenwood TA, Swerdlow NR, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 24903414; PMCID: PMC4193725.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    97. Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings. Psychiatry Res. 2014 Sep 30; 219(1):67-71. Schmeidler J, Lazzeroni LC, Swerdlow NR, Ferreira RP, Braff DL, Calkins ME, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Olincy A, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Stone WS, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Silverman JM. PMID: 24913833; PMCID: PMC4110721.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    98. Neural substrates of visual masking by object substitution in schizophrenia. Hum Brain Mapp. 2014 Sep; 35(9):4654-62. Lee J, Cohen MS, Engel SA, Glahn D, Nuechterlein KH, Wynn JK, Green MF. PMID: 24677632; PMCID: PMC6716599.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    99. A novel, online social cognitive training program for young adults with schizophrenia: A pilot study. Schizophr Res Cogn. 2014 Mar 01; 1(1):e11-e19. Nahum M, Fisher M, Loewy R, Poelke G, Ventura J, Nuechterlein KH, Hooker CI, Green MF, Merzenich M, Vinogradov S. PMID: 25267937; PMCID: PMC4175473.
      View in: PubMed   Mentions: 47  
    100. The relationship of attitudinal beliefs to negative symptoms, neurocognition, and daily functioning in recent-onset schizophrenia. Schizophr Bull. 2014 Nov; 40(6):1308-18. Ventura J, Subotnik KL, Ered A, Gretchen-Doorly D, Hellemann GS, Vaskinn A, Nuechterlein KH. PMID: 24561318; PMCID: PMC4193707.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    101. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? PLoS One. 2014; 9(2):e88379. Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, Olincy A, Nuechterlein K, Seidman L, Siever L, Silverman J, Stone W, Sprock J, Sugar C, Swerdlow N, Tsuang M, Turetsky B, Radant A. PMID: 24523888; PMCID: PMC3921166.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    102. Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. Schizophr Res. 2014 Feb; 152(2-3):503-12. Swerdlow NR, Light GA, Sprock J, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Ray A, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 24405980; PMCID: PMC3960985.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    103. The early longitudinal course of cognitive deficits in schizophrenia. J Clin Psychiatry. 2014; 75 Suppl 2:25-9. Nuechterlein KH, Ventura J, Subotnik KL, Bartzokis G. PMID: 24919168; PMCID: PMC4081490.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    104. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry. 2013 May; 170(5):521-32. Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Light GA, Braff DL. PMID: 23511790; PMCID: PMC3878873.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    105. Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biol Psychiatry. 2013 May 15; 73(10):976-84. Calkins ME, Ray A, Gur RC, Freedman R, Green MF, Greenwood TA, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar C, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL, Lazzeroni LC, Gur RE. PMID: 23395246; PMCID: PMC3954126.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    106. Managing disclosure following recent-onset psychosis: utilizing the individual placement and support model. Early Interv Psychiatry. 2013 Aug; 7(3):338-44. Allott KA, Turner LR, Chinnery GL, Killackey EJ, Nuechterlein KH. PMID: 23343040.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    107. Statistical shape analysis of the corpus callosum in Schizophrenia. Neuroimage. 2013 Jan 01; 64:547-59. Joshi SH, Narr KL, Philips OR, Nuechterlein KH, Asarnow RF, Toga AW, Woods RP. PMID: 23000788; PMCID: PMC3615906.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    108. Disease and genetic contributions toward local tissue volume disturbances in schizophrenia: a tensor-based morphometry study. Hum Brain Mapp. 2012 Sep; 33(9):2081-91. Yang Y, Nuechterlein KH, Phillips OR, Gutman B, Kurth F, Dinov I, Thompson PM, Asarnow RF, Toga AW, Narr KL. PMID: 22241649; PMCID: PMC3330198.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    109. Spectral decomposition of P50 suppression in schizophrenia during concurrent visual processing. Schizophr Res. 2012 Sep; 140(1-3):237-42. Moran ZD, Williams TJ, Bachman P, Nuechterlein KH, Subotnik KL, Yee CM. PMID: 22840844; PMCID: PMC3435431.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    110. Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia. Schizophr Res. 2012 Sep; 140(1-3):122-8. Bartzokis G, Lu PH, Raven EP, Amar CP, Detore NR, Couvrette AJ, Mintz J, Ventura J, Casaus LR, Luo JS, Subotnik KL, Nuechterlein KH. PMID: 22809684; PMCID: PMC3567927.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    111. The interaction of electrodermal activity and expressed emotion in predicting symptoms in recent-onset schizophrenia. Psychophysiology. 2012 Aug; 49(8):1035-8. Subotnik KL, Schell AM, Chilingar MS, Dawson ME, Ventura J, Kelly KA, Hellemann GS, Nuechterlein KH. PMID: 22680838; PMCID: PMC3399973.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    112. The puzzle of schizophrenia: tracking the core role of cognitive deficits. Dev Psychopathol. 2012 May; 24(2):529-36. Nuechterlein KH, Subotnik KL, Ventura J, Green MF, Gretchen-Doorly D, Asarnow RF. PMID: 22559128.
      View in: PubMed   Mentions: 8  Translation:Humans
    113. Cardiorespiratory endurance, muscular flexibility and strength in first-episode schizophrenia patients: use of a standardized fitness assessment. Early Interv Psychiatry. 2012 May; 6(2):185-90. Gretchen-Doorly D, Kite RE, Subotnik KL, Detore NR, Ventura J, Kurtz AS, Nuechterlein KH. PMID: 22168582.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    114. Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull. 2011 Sep; 37 Suppl 2:S33-40. Nuechterlein KH, Subotnik KL, Green MF, Ventura J, Asarnow RF, Gitlin MJ, Yee CM, Gretchen-Doorly D, Mintz J. PMID: 21860045; PMCID: PMC3160123.
      View in: PubMed   Mentions: 118     Fields:    Translation:Humans
    115. Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory. Schizophr Res. 2011 Oct; 132(1):35-41. Bartzokis G, Lu PH, Amar CP, Raven EP, Detore NR, Altshuler LL, Mintz J, Ventura J, Casaus LR, Luo JS, Subotnik KL, Nuechterlein KH. PMID: 21767934; PMCID: PMC3172389.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCellsCTClinical Trials
    116. Remission and recovery during the first outpatient year of the early course of schizophrenia. Schizophr Res. 2011 Oct; 132(1):18-23. Ventura J, Subotnik KL, Guzik LH, Hellemann GS, Gitlin MJ, Wood RC, Nuechterlein KH. PMID: 21764563; PMCID: PMC3172347.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansPHPublic Health
    117. Mapping corticocortical structural integrity in schizophrenia and effects of genetic liability. Biol Psychiatry. 2011 Oct 01; 70(7):680-9. Phillips OR, Nuechterlein KH, Asarnow RF, Clark KA, Cabeen R, Yang Y, Woods RP, Toga AW, Narr KL. PMID: 21571255; PMCID: PMC3838300.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    118. The attentional blink in schizophrenia: isolating the perception/attention interface. J Psychiatr Res. 2011 Oct; 45(10):1346-51. Mathis KI, Wynn JK, Breitmeyer B, Nuechterlein KH, Green MF. PMID: 21550051; PMCID: PMC3183173.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    119. Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biol Psychiatry. 2011 Jul 01; 70(1):7-12. Carter CS, Barch DM, Bullmore E, Breiling J, Buchanan RW, Butler P, Cohen JD, Geyer M, Gollub R, Green MF, Jaeger J, Krystal JH, Moore H, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T. PMID: 21529781; PMCID: PMC3116022.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimals
    120. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry. 2011 Sep; 168(9):930-46. Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Gur RE, Gur RC, Hardiman G, Kelsoe JR, Leonard S, Light GA, Nuechterlein KH, Olincy A, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Freedman R, Braff DL. PMID: 21498463; PMCID: PMC3751972.
      View in: PubMed   Mentions: 135     Fields:    Translation:Humans
    121. Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophr Bull. 2012 Jun; 38(4):865-72. Horan WP, Green MF, DeGroot M, Fiske A, Hellemann G, Kee K, Kern RS, Lee J, Sergi MJ, Subotnik KL, Sugar CA, Ventura J, Nuechterlein KH. PMID: 21382881; PMCID: PMC3406537.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    122. Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia. Psychol Assess. 2011 Mar; 23(1):245-61. Reise SP, Ventura J, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder R. PMID: 21381848; PMCID: PMC3183749.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    123. Social cognition in schizophrenia, Part 1: performance across phase of illness. Schizophr Bull. 2012 Jun; 38(4):854-64. Green MF, Bearden CE, Cannon TD, Fiske AP, Hellemann GS, Horan WP, Kee K, Kern RS, Lee J, Sergi MJ, Subotnik KL, Sugar CA, Ventura J, Yee CM, Nuechterlein KH. PMID: 21345917; PMCID: PMC3406534.
      View in: PubMed   Mentions: 139     Fields:    Translation:Humans
    124. Mean diffusivity and fractional anisotropy as indicators of disease and genetic liability to schizophrenia. J Psychiatr Res. 2011 Jul; 45(7):980-8. Clark KA, Nuechterlein KH, Asarnow RF, Hamilton LS, Phillips OR, Hageman NS, Woods RP, Alger JR, Toga AW, Narr KL. PMID: 21306734; PMCID: PMC3109158.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    125. Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res. 2011 May; 128(1-3):102-10. Stone WS, Giuliano AJ, Tsuang MT, Braff DL, Cadenhead KS, Calkins ME, Dobie DJ, Faraone SV, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Roe AH, Schork NJ, Siever LJ, Silverman JM, Swerdlow NR, Thomas AR, Tsuang DW, Turetsky BI, Seidman LJ. PMID: 21288694; PMCID: PMC6819951.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    126. Norman Garmezy (1918-2009). Am Psychol. 2011 Feb-Mar; 66(2):140-1. Masten AS, Nuechterlein KH, Wright MO. PMID: 21299255.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    127. Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia. Am J Psychiatry. 2011 Mar; 168(3):286-92. Subotnik KL, Nuechterlein KH, Ventura J, Gitlin MJ, Marder S, Mintz J, Hellemann GS, Thornton LA, Singh IR. PMID: 21205805; PMCID: PMC5069345.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansPHPublic Health
    128. Altered dynamic coupling of lateral occipital complex during visual perception in schizophrenia. Neuroimage. 2011 Apr 01; 55(3):1219-26. Harvey PO, Lee J, Cohen MS, Engel SA, Glahn DC, Nuechterlein KH, Wynn JK, Green MF. PMID: 21194569; PMCID: PMC3049854.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    129. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophr Res. 2011 Mar; 126(1-3):124-31. Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Baade LE, Keefe RS, Mesholam-Gately RI, Seidman LJ, Lee C, Sugar CA, Marder SR. PMID: 21159492; PMCID: PMC3050090.
      View in: PubMed   Mentions: 110     Fields:    Translation:Humans
    130. The cultural adaptability of intermediate measures of functional outcome in schizophrenia. Schizophr Bull. 2012 May; 38(3):630-41. Velligan DI, Rubin M, Fredrick MM, Mintz J, Nuechterlein KH, Schooler NR, Jaeger J, Peters NM, Buller R, Marder SR, Dube S. PMID: 21134973; PMCID: PMC3329974.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    131. The contributions of disease and genetic factors towards regional cortical thinning in schizophrenia: the UCLA family study. Schizophr Res. 2010 Nov; 123(2-3):116-25. Yang Y, Nuechterlein KH, Phillips O, Hamilton LS, Subotnik KL, Asarnow RF, Toga AW, Narr KL. PMID: 20817413; PMCID: PMC2988766.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    132. Topographical relationships between arcuate fasciculus connectivity and cortical thickness. Hum Brain Mapp. 2011 Nov; 32(11):1788-801. Phillips OR, Clark KA, Woods RP, Subotnik KL, Asarnow RF, Nuechterlein KH, Toga AW, Narr KL. PMID: 20886580; PMCID: PMC3071430.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    133. Distinct neural generators of sensory gating in schizophrenia. Psychophysiology. 2011 Apr; 48(4):470-8. Williams TJ, Nuechterlein KH, Subotnik KL, Yee CM. PMID: 20735757; PMCID: PMC2994969.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    134. Psychophysiological prodromal signs of schizophrenic relapse: a pilot study. Schizophr Res. 2010 Oct; 123(1):64-7. Dawson ME, Schell AM, Rissling A, Ventura J, Subotnik KL, Nuechterlein KH. PMID: 20724111; PMCID: PMC4128618.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    135. Relationships between perceptions of the family environment and of negative life events in recent-onset schizophrenia patients. Schizophr Res. 2011 Apr; 127(1-3):266-7. Gretchen-Doorly D, Detore NR, Ventura J, Hellemann G, Subotnik KL, Nuechterlein KH. PMID: 20719475; PMCID: PMC2998552.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    136. The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. Schizophr Res. 2010 Aug; 121(1-3):24-31. Ventura J, Reise SP, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder RM. PMID: 20542412; PMCID: PMC3184638.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    137. Latest developments in the matrics process. Psychiatry (Edgmont). 2010 Jun; 7(6):49-52. Harvey PD, Green MF, Nuechterlein KH. PMID: 20622946; PMCID: PMC2898842.
      View in: PubMed   Mentions: 7  
    138. Regional brain activity during early visual perception in unaffected siblings of schizophrenia patients. Biol Psychiatry. 2010 Jul 01; 68(1):78-85. Lee J, Cohen MS, Engel SA, Glahn D, Nuechterlein KH, Wynn JK, Green MF. PMID: 20494338; PMCID: PMC2921272.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    139. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res. 2010 Jun; 119(1-3):175-82. Olincy A, Braff DL, Adler LE, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Wagner BD, Freedman R. PMID: 20382002; PMCID: PMC3688282.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    140. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology. 2010 Sep; 47(5):846-56. Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW. PMID: 20374545; PMCID: PMC4176871.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    141. Integrity of emotional and motivational states during the prodromal, first-episode, and chronic phases of schizophrenia. J Abnorm Psychol. 2010 Feb; 119(1):71-82. Yee CM, Mathis KI, Sun JC, Sholty GL, Lang PJ, Bachman P, Williams TJ, Bearden CE, Cannon TD, Green MF, Subotnik KL, Ventura J, Nuechterlein KH. PMID: 20141244; PMCID: PMC2853376.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    142. Attentional modulation of the P50 suppression deficit in recent-onset and chronic schizophrenia. J Abnorm Psychol. 2010 Feb; 119(1):31-9. Yee CM, Williams TJ, White PM, Nuechterlein KH, Ames D, Subotnik KL. PMID: 20141240; PMCID: PMC2844773.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    143. Functional neuroanatomy of visual masking deficits in schizophrenia. Arch Gen Psychiatry. 2009 Dec; 66(12):1295-303. Green MF, Lee J, Cohen MS, Engel SA, Korb AS, Nuechterlein KH, Wynn JK, Glahn DC. PMID: 19996034; PMCID: PMC2907419.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    144. Alterations in functional activation in euthymic bipolar disorder and schizophrenia during a working memory task. Hum Brain Mapp. 2009 Dec; 30(12):3958-69. Hamilton LS, Altshuler LL, Townsend J, Bookheimer SY, Phillips OR, Fischer J, Woods RP, Mazziotta JC, Toga AW, Nuechterlein KH, Narr KL. PMID: 19449330; PMCID: PMC2787769.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    145. Elucidating a magnetic resonance imaging-based neuroanatomic biomarker for psychosis: classification analysis using probabilistic brain atlas and machine learning algorithms. Biol Psychiatry. 2009 Dec 01; 66(11):1055-60. Sun D, van Erp TG, Thompson PM, Bearden CE, Daley M, Kushan L, Hardt ME, Nuechterlein KH, Toga AW, Cannon TD. PMID: 19729150; PMCID: PMC3192809.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    146. Symptomatic and functional correlates of regional brain physiology during working memory processing in patients with recent onset schizophrenia. Psychiatry Res. 2009 Sep 30; 173(3):177-82. Sanz JH, Karlsgodt KH, Bearden CE, van Erp TG, Nandy RR, Ventura J, Nuechterlein K, Cannon TD. PMID: 19692211; PMCID: PMC2734873.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    147. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr Res. 2009 Sep; 113(2-3):189-99. Ventura J, Hellemann GS, Thames AD, Koellner V, Nuechterlein KH. PMID: 19628375; PMCID: PMC2825750.
      View in: PubMed   Mentions: 177     Fields:    Translation:Humans
    148. In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophr Res. 2009 Sep; 113(2-3):322-31. Bartzokis G, Lu PH, Stewart SB, Oluwadara B, Lucas AJ, Pantages J, Pratt E, Sherin JE, Altshuler LL, Mintz J, Gitlin MJ, Subotnik KL, Nuechterlein KH. PMID: 19616412; PMCID: PMC2862048.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    149. Expressed emotion, human agency, and schizophrenia: toward a new model for the EE-relapse association. Cult Med Psychiatry. 2009 Mar; 33(1):41-60. Breitborde NJ, López SR, Nuechterlein KH. PMID: 19115098.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    150. Development of a measure of relationship perception in schizophrenia. Psychiatry Res. 2009 Mar 31; 166(1):54-62. Sergi MJ, Fiske AP, Horan WP, Kern RS, Kee KS, Subotnik KL, Nuechterlein KH, Green MF. PMID: 19193447.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    151. Re-evaluating dorsolateral prefrontal cortex activation during working memory in schizophrenia. Schizophr Res. 2009 Mar; 108(1-3):143-50. Karlsgodt KH, Sanz J, van Erp TG, Bearden CE, Nuechterlein KH, Cannon TD. PMID: 19196494; PMCID: PMC2671001.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    152. CNTRICS final task selection: control of attention. Schizophr Bull. 2009 Jan; 35(1):182-96. Nuechterlein KH, Luck SJ, Lustig C, Sarter M. PMID: 19074499; PMCID: PMC2617743.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimals
    153. Neurodevelopmental factors associated with schizotypal symptoms among adolescents at risk for schizophrenia. Dev Psychopathol. 2009; 21(4):1195-210. Hans SL, Auerbach JG, Nuechterlein KH, Asarnow RF, Asarnow J, Styr B, Marcus J. PMID: 19825264.
      View in: PubMed   Mentions: 3  Translation:Humans
    154. Development and evaluation of a health promotion group for individuals with severe psychiatric disabilities. Psychiatr Rehabil J. 2009; 33(1):56-9. Gretchen-Doorly D, Subotnik KL, Kite RE, Alarcon E, Nuechterlein KH. PMID: 19592382.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    155. Mean diffusivity: a biomarker for CSF-related disease and genetic liability effects in schizophrenia. Psychiatry Res. 2009 Jan 30; 171(1):20-32. Narr KL, Hageman N, Woods RP, Hamilton LS, Clark K, Phillips O, Shattuck DW, Asarnow RF, Toga AW, Nuechterlein KH. PMID: 19081707; PMCID: PMC2665171.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    156. Fiber tractography reveals disruption of temporal lobe white matter tracts in schizophrenia. Schizophr Res. 2009 Jan; 107(1):30-8. Phillips OR, Nuechterlein KH, Clark KA, Hamilton LS, Asarnow RF, Hageman NS, Toga AW, Narr KL. PMID: 19028423; PMCID: PMC2655322.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    157. Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull. 2009 Jan; 35(1):109-14. Barch DM, Carter CS, Arnsten A, Buchanan RW, Cohen JD, Geyer M, Green MF, Krystal JH, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R. PMID: 19023126; PMCID: PMC2643950.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    158. CMINDS does not have identical tests to the CATIE and MATRICS batteries. Commentary on O'Halloran et al. Schizophr Res. 2009 Feb; 107(2-3):327-9; author reply 330-1. Kern RS, Green MF, Nuechterlein KH, Keefe RS. PMID: 19013770.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    159. Increased extent of object-selective cortex in schizophrenia. Psychiatry Res. 2008 Nov 30; 164(2):97-105. Wynn JK, Green MF, Engel S, Korb A, Lee J, Glahn D, Nuechterlein KH, Cohen MS. PMID: 18938066; PMCID: PMC2683746.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    160. Emotional intelligence in schizophrenia. Schizophr Res. 2009 Jan; 107(1):61-8. Kee KS, Horan WP, Salovey P, Kern RS, Sergi MJ, Fiske AP, Lee J, Subotnik KL, Nuechterlein K, Sugar CA, Green MF. PMID: 18805674.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    161. Impaired implicit learning in schizophrenia. Neuropsychology. 2008 Sep; 22(5):606-17. Horan WP, Green MF, Knowlton BJ, Wynn JK, Mintz J, Nuechterlein KH. PMID: 18763880; PMCID: PMC2548320.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    162. Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry. 2008 Dec 15; 64(12):1051-9. Turetsky BI, Greenwood TA, Olincy A, Radant AD, Braff DL, Cadenhead KS, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Calkins ME. PMID: 18701089; PMCID: PMC2653714.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    163. Executive functioning component mechanisms and schizophrenia. Biol Psychiatry. 2008 Jul 01; 64(1):26-33. Kerns JG, Nuechterlein KH, Braver TS, Barch DM. PMID: 18549874.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    164. Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry. 2008 Jul 01; 64(1):4-10. Carter CS, Barch DM, Buchanan RW, Bullmore E, Krystal JH, Cohen J, Geyer M, Green M, Nuechterlein KH, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R. PMID: 18466880; PMCID: PMC2577821.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansAnimals
    165. Stability of visual masking performance in recent-onset schizophrenia: an 18-month longitudinal study. Schizophr Res. 2008 Aug; 103(1-3):266-74. Lee J, Nuechterlein KH, Subotnik KL, Sugar CA, Ventura J, Gretchen-Doorly D, Kelly K, Green MF. PMID: 18450427; PMCID: PMC2859819.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    166. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res. 2008 Aug; 103(1-3):218-28. Horan WP, Braff DL, Nuechterlein KH, Sugar CA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Olincy A, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Green MF. PMID: 18406578; PMCID: PMC2529172.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    167. Probing attentional dysfunctions in schizophrenia: Startle modification during a continuous performance test. Psychophysiology. 2008 Jul; 45(4):632-42. Hazlett EA, Dawson ME, Schell AM, Nuechterlein KH. PMID: 18282203.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    168. The validity of Psychosis Proneness Scales as vulnerability indicators in recent-onset schizophrenia patients. Schizophr Res. 2008 Mar; 100(1-3):224-36. Horan WP, Reise SP, Subotnik KL, Ventura J, Nuechterlein KH. PMID: 18221857; PMCID: PMC2346539.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    169. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. Am J Psychiatry. 2008 Feb; 165(2):221-8. Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR. PMID: 18172017.
      View in: PubMed   Mentions: 108     Fields:    Translation:Humans
    170. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008 Feb; 165(2):203-13. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR. PMID: 18172019.
      View in: PubMed   Mentions: 954     Fields:    Translation:Humans
    171. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry. 2008 Feb; 165(2):214-20. Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, Stover E, Marder SR. PMID: 18172018.
      View in: PubMed   Mentions: 300     Fields:    Translation:Humans
    172. Does the central bottleneck encompass voluntary selection of hedonically based choices? Exp Psychol. 2008; 55(5):313-21. Pashler H, Harris CR, Nuechterlein KH. PMID: 25116298.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    173. Selective corticostriatal dysfunction in schizophrenia: examination of motor and cognitive skill learning. Neuropsychology. 2008 Jan; 22(1):100-9. Foerde K, Poldrack RA, Khan BJ, Sabb FW, Bookheimer SY, Bilder RM, Guthrie D, Granholm E, Nuechterlein KH, Marder SR, Asarnow RF. PMID: 18211159.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    174. Individual placement and support for individuals with recent-onset schizophrenia: integrating supported education and supported employment. Psychiatr Rehabil J. 2008; 31(4):340-9. Nuechterlein KH, Subotnik KL, Turner LR, Ventura J, Becker DR, Drake RE. PMID: 18407884.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    175. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry. 2007 Nov; 64(11):1242-50. Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Schork NJ. PMID: 17984393; PMCID: PMC10588564.
      View in: PubMed   Mentions: 186     Fields:    Translation:Humans
    176. Remember and know judgments during recognition in chronic schizophrenia. Schizophr Res. 2008 Mar; 100(1-3):181-90. van Erp TG, Lesh TA, Knowlton BJ, Bearden CE, Hardt M, Karlsgodt KH, Shirinyan D, Rao V, Green MF, Subotnik KL, Nuechterlein K, Cannon TD. PMID: 17964760; PMCID: PMC2517628.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    177. Diffusion tensor imaging of the superior longitudinal fasciculus and working memory in recent-onset schizophrenia. Biol Psychiatry. 2008 Mar 01; 63(5):512-8. Karlsgodt KH, van Erp TG, Poldrack RA, Bearden CE, Nuechterlein KH, Cannon TD. PMID: 17720147.
      View in: PubMed   Mentions: 152     Fields:    Translation:HumansCells
    178. Effects of cigarette smoking on prepulse inhibition, its attentional modulation, and vigilance performance. Psychophysiology. 2007 Jul; 44(4):627-34. Rissling AJ, Dawson ME, Schell AM, Nuechterlein KH. PMID: 17521379.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    179. Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr Res. 2007 Jul; 93(1-3):13-22. Bartzokis G, Lu PH, Nuechterlein KH, Gitlin M, Doi C, Edwards N, Lieu C, Altshuler LL, Mintz J. PMID: 17407804; PMCID: PMC1974878.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    180. Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res. 2007 May; 92(1-3):237-51. Swerdlow NR, Sprock J, Light GA, Cadenhead K, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Mintz J, Olincy A, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 17346930; PMCID: PMC2039885.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    181. The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes. Schizophr Bull. 2007 Jan; 33(1):49-68. Gur RE, Calkins ME, Gur RC, Horan WP, Nuechterlein KH, Seidman LJ, Stone WS. PMID: 17101692; PMCID: PMC2632287.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    182. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull. 2007 Jan; 33(1):33-48. Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 17035358; PMCID: PMC2632302.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    183. Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res. 2007 Jan; 89(1-3):320-9. Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Light GA, Meichle SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW. PMID: 17023145.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    184. Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples. Psychiatry Res. 2006 Nov 15; 144(2-3):153-66. Nuechterlein KH, Miklowitz DJ, Ventura J, Gitlin MJ, Stoddard M, Lukoff D. PMID: 17011635.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    185. Exploring the short term visual store in schizophrenia using the attentional blink. J Psychiatr Res. 2006 Oct; 40(7):599-605. Wynn JK, Breitmeyer B, Nuechterlein KH, Green MF. PMID: 16890242.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    186. Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? J Abnorm Psychol. 2006 Aug; 115(3):496-508. Horan WP, Green MF, Kring AM, Nuechterlein KH. PMID: 16866590.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    187. Electrophysiological analysis of error monitoring in schizophrenia. J Abnorm Psychol. 2006 May; 115(2):239-50. Morris SE, Yee CM, Nuechterlein KH. PMID: 16737389.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    188. Neurocognitive and social cognitive correlates of formal thought disorder in schizophrenia patients. Schizophr Res. 2006 Jul; 85(1-3):84-95. Subotnik KL, Nuechterlein KH, Green MF, Horan WP, Nienow TM, Ventura J, Nguyen AT. PMID: 16624529.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    189. Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res. 2006 May; 84(1):100-11. Niendam TA, Bearden CE, Johnson JK, McKinley M, Loewy R, O'Brien M, Nuechterlein KH, Green MF, Cannon TD. PMID: 16563699.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    190. Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. Am J Psychiatry. 2006 Mar; 163(3):448-54. Sergi MJ, Rassovsky Y, Nuechterlein KH, Green MF. PMID: 16513866.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    191. Do recent-onset schizophrenia patients experience a "social network crisis"? Psychiatry. 2006; 69(2):115-29. Horan WP, Subotnik KL, Snyder KS, Nuechterlein KH. PMID: 16822191.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    192. Translating basic attentional paradigms to schizophrenia research: reconsidering the nature of the deficits. Dev Psychopathol. 2006; 18(3):831-51. Nuechterlein KH, Pashler HE, Subotnik KL. PMID: 17152403.
      View in: PubMed   Mentions: 9  Translation:Humans
    193. Event-related gamma activity in schizophrenia patients during a visual backward-masking task. Am J Psychiatry. 2005 Dec; 162(12):2330-6. Wynn JK, Light GA, Breitmeyer B, Nuechterlein KH, Green MF. PMID: 16330598; PMCID: PMC9973373.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    194. Visual processing in schizophrenia: Structural equation modeling of visual masking performance. Schizophr Res. 2005 Oct 15; 78(2-3):251-60. Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer BG, Mintz J. PMID: 15975768.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    195. Dorsolateral prefrontal cortex activity during maintenance and manipulation of information in working memory in patients with schizophrenia. Arch Gen Psychiatry. 2005 Oct; 62(10):1071-80. Cannon TD, Glahn DC, Kim J, Van Erp TG, Karlsgodt K, Cohen MS, Nuechterlein KH, Bava S, Shirinyan D. PMID: 16203952.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    196. Distinguishing separable domains of cognition in human and animal studies: what separations are optimal for targeting interventions? A summary of recommendations from breakout group 2 at the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr Bull. 2005 Oct; 31(4):870-4. Nuechterlein KH, Robbins TW, Einat H. PMID: 16150960.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    197. Forward and backward visual masking in unaffected siblings of schizophrenic patients. Biol Psychiatry. 2006 Mar 01; 59(5):446-51. Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. PMID: 16139818.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    198. Modulation of attention during visual masking in schizophrenia. Am J Psychiatry. 2005 Aug; 162(8):1533-5. Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. PMID: 16055778.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    199. Stability and clinical correlates of personality characteristics in recent-onset schizophrenia. Psychol Med. 2005 Jul; 35(7):995-1005. Horan WP, Subotnik KL, Reise SP, Ventura J, Nuechterlein KH. PMID: 16045066.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    200. Effects of perceptual processing demands on startle eyeblink modification. Psychophysiology. 2005 Jul; 42(4):440-6. Rissling AJ, Dawson ME, Schell AM, Nuechterlein KH. PMID: 16008772.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    201. Electrodermal predictors of functional outcome and negative symptoms in schizophrenia. Psychophysiology. 2005 Jul; 42(4):483-92. Schell AM, Dawson ME, Rissling A, Ventura J, Subotnik KL, Gitlin MJ, Nuechterlein KH. PMID: 16008777.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    202. Stressful life events in recent-onset schizophrenia: reduced frequencies and altered subjective appraisals. Schizophr Res. 2005 Jun 15; 75(2-3):363-74. Horan WP, Ventura J, Nuechterlein KH, Subotnik KL, Hwang SS, Mintz J. PMID: 15885527.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    203. An illustration of multilevel factor analysis. J Pers Assess. 2005 Apr; 84(2):126-36. Reise SP, Ventura J, Nuechterlein KH, Kim KH. PMID: 15799887.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    204. MMPI vulnerability indicators for schizophrenia and attention deficit disorder: UCLA family study of biological parents of offspring with childhood-onset schizophrenia or ADHD. Behav Genet. 2005 Mar; 35(2):159-75. Subotnik KL, Asarnow RF, Nuechterlein KH, Fogelson DL, Thorpe TI, Payne DL, Giannini CA, Kuppinger HE, Torquato RD, Mintz J, Hwang SS, Gottesman II. PMID: 15685429.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    205. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull. 2005 Jan; 31(1):5-19. Buchanan RW, Davis M, Goff D, Green MF, Keefe RS, Leon AC, Nuechterlein KH, Laughren T, Levin R, Stover E, Fenton W, Marder SR. PMID: 15888422.
      View in: PubMed   Mentions: 175     Fields:    Translation:Humans
    206. Is unawareness of psychotic disorder a neurocognitive or psychological defensiveness problem? Schizophr Res. 2005 Jun 15; 75(2-3):147-57. Subotnik KL, Nuechterlein KH, Irzhevsky V, Kitchen CM, Woo SM, Mintz J. PMID: 15885506.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    207. Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task. Schizophr Res. 2005 Jan 01; 72(2-3):215-24. Shurman B, Horan WP, Nuechterlein KH. PMID: 15560966.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    208. Regional brain activity associated with visual backward masking. J Cogn Neurosci. 2005 Jan; 17(1):13-23. Green MF, Glahn D, Engel SA, Nuechterlein KH, Sabb F, Strojwas M, Cohen MS. PMID: 15701236.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    209. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res. 2004 Dec 15; 72(1):1-3. Green MF, Nuechterlein KH. PMID: 15531401.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    210. Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004 Dec 15; 72(1):29-39. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. PMID: 15531405.
      View in: PubMed   Mentions: 408     Fields:    Translation:Humans
    211. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr Res. 2004 Dec 15; 72(1):11-9. Kern RS, Green MF, Nuechterlein KH, Deng BH. PMID: 15531403.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    212. Paracontrast and metacontrast in schizophrenia: clarifying the mechanism for visual masking deficits. Schizophr Res. 2004 Dec 01; 71(2-3):485-92. Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. PMID: 15474919.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    213. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry. 2004 Sep 01; 56(5):301-7. Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR. PMID: 15336511.
      View in: PubMed   Mentions: 289     Fields:    Translation:Humans
    214. Self-efficacy and neurocognition may be related to coping responses in recent-onset schizophrenia. Schizophr Res. 2004 Aug 01; 69(2-3):343-52. Ventura J, Nuechterlein KH, Subotnik KL, Green MF, Gitlin MJ. PMID: 15469206.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    215. The timing of negative symptom exacerbations in relationship to positive symptom exacerbations in the early course of schizophrenia. Schizophr Res. 2004 Aug 01; 69(2-3):333-42. Ventura J, Nuechterlein KH, Green MF, Horan WP, Subotnik KL, Mintz J. PMID: 15469205.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    216. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging. 2004 Aug; 25(7):843-51. Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL. PMID: 15212838.
      View in: PubMed   Mentions: 184     Fields:    Translation:HumansCellsCTClinical Trials
    217. Maintenance and manipulation of information in schizophrenia: further evidence for impairment in the central executive component of working memory. Schizophr Res. 2004 Jun 01; 68(2-3):173-87. Kim J, Glahn DC, Nuechterlein KH, Cannon TD. PMID: 15099601.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    218. Validity of the family history method for diagnosing schizophrenia, schizophrenia-related psychoses, and schizophrenia-spectrum personality disorders in first-degree relatives of schizophrenia probands. Schizophr Res. 2004 Jun 01; 68(2-3):309-17. Fogelson DL, Nuechterlein KH, Asarnow RF, Payne DL, Subotnik KL. PMID: 15099612.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    219. Relatives' affective style and the expression of subclinical psychopathology in patients with schizophrenia. Fam Process. 2004 Jun; 43(2):233-47. Woo SM, Goldstein MJ, Nuechterlein KH. PMID: 15603506.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    220. Dynamic testing in schizophrenia: does training change the construct validity of a test? Schizophr Bull. 2004; 30(4):703-11. Wiedl KH, Schöttke H, Green MF, Nuechterlein KH. PMID: 15954185.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    221. Intra- and interindividual variations in steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients treated chronically with various doses of risperidone. Ther Drug Monit. 2003 Dec; 25(6):657-64. Aravagiri M, Marder SR, Nuechterlein KH, Gitlin MJ. PMID: 14639051.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    222. A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. Am J Psychiatry. 2003 Nov; 160(11):2060-2. Niendam TA, Bearden CE, Rosso IM, Sanchez LE, Hadley T, Nuechterlein KH, Cannon TD. PMID: 14594759.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    223. Visual masking as a probe for abnormal gamma range activity in schizophrenia. Biol Psychiatry. 2003 Jun 15; 53(12):1113-9. Green MF, Mintz J, Salveson D, Nuechterlein KH, Breitmeyer B, Light GA, Braff DL. PMID: 12814862.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    224. Neuroanatomical correlates of formal thought disorder in schizophrenia. Cogn Neuropsychiatry. 2003 May; 8(2):81-8. Subotnik KL, Bartzokis G, Green MF, Nuechterlein KH. PMID: 16571552.
      View in: PubMed   Mentions: 8     Fields:    
    225. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol Psychiatry. 2003 Mar 01; 53(5):412-21. Bartzokis G, Nuechterlein KH, Lu PH, Gitlin M, Rogers S, Mintz J. PMID: 12614994.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    226. White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol. 2003 Mar; 60(3):393-8. Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J. PMID: 12633151.
      View in: PubMed   Mentions: 167     Fields:    Translation:HumansCells
    227. Neurocognitive impairments in nonpsychotic parents of children with schizophrenia and attention-deficit/hyperactivity disorder: the University of California, Los Angeles Family Study. Arch Gen Psychiatry. 2002 Nov; 59(11):1053-60. Asarnow RF, Nuechterlein KH, Subotnik KL, Fogelson DL, Torquato RD, Payne DL, Asamen J, Mintz J, Guthrie D. PMID: 12418939.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    228. The temporal stability of electrodermal variables over a one-year period in patients with recent-onset schizophrenia and in normal subjects. Psychophysiology. 2002 Mar; 39(2):124-32. Schell AM, Dawson ME, Nuechterlein KH, Subotnik KL, Ventura J. PMID: 12212661.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    229. The structure of schizotypy: relationships between neurocognitive and personality disorder features in relatives of schizophrenic patients in the UCLA Family Study. Schizophr Res. 2002 Mar 01; 54(1-2):121-30. Nuechterlein KH, Asarnow RF, Subotnik KL, Fogelson DL, Payne DL, Kendler KS, Neale MC, Jacobson KC, Mintz J. PMID: 11853986.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    230. Neurocognitive functioning and schizophrenia spectrum disorders can be independent expressions of familial liability for schizophrenia in community control children: the UCLA family study. Schizophr Res. 2002 Mar 01; 54(1-2):111-20. Asarnow RF, Nuechterlein KH, Asamen J, Fogelson D, Subotnik KL, Zaucha K, Guthrie D. PMID: 11853985.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    231. Withholding proven treatment in research. N Engl J Med. 2002 Feb 07; 346(6):455-6. Nuechterlein KH. PMID: 11832540.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    232. Development of a computerized assessment for visual masking. Int J Methods Psychiatr Res. 2002; 11(2):83-9. Green MF, Nuechterlein KH, Breitmeyer B. PMID: 12459798; PMCID: PMC6878354.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    233. Are communication deviance and expressed emotion related to family history of psychiatric disorders in schizophrenia? Schizophr Bull. 2002; 28(4):719-29. Subotnik KL, Goldstein MJ, Nuechterlein KH, Woo SM, Mintz J. PMID: 12795501.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Keith's Networks
    Concepts (437)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (58)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California